Ultragenyx Pharmaceutical Revenue

In the year 2024, Ultragenyx Pharmaceutical had annual revenue of $560.23M USD with 29.01% growth. Ultragenyx Pharmaceutical had revenue of $164.88M in the quarter ending December 31, 2024, with 29.42% growth.

Revenue

$560.23M

Revenue Growth

+29.01%

P/S Ratio

6.15

Revenue / Employee

$432.94K

Employees

1,294

Market Cap

2.75B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	560.23M	125.98M	29.01%
Dec 31, 2023	434.25M	70.92M	19.52%
Dec 31, 2022	363.33M	11.92M	3.39%
Dec 31, 2021	351.41M	80.38M	29.66%
Dec 31, 2020	271.03M	167.32M	161.32%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
AstraZeneca	42.56B
Shell	227.10B
HSBC Holdings	44.89B
Unilever	50.25B
Rio Tinto Group	42.86B
RELX PLC	9.43B
British American Tobacco p.l.c.	25.87B
Rolls-Royce Holdings	18.91B

Revenue Rankings